ESGO meta-analysis for triage of HPV-positive cases
ESGO eAcademy, Marc Arbyn, 282760
Endometrial cancer
ESGO eAcademy, Nadeem Abu Rustum, 282766
Up-to-date in cervical cancer screening: ESGO-EFC joint statement
ESGO eAcademy, Jack Cuzick, 282759
Cervical cancer
ESGO eAcademy, David Cibula, 282765
State of the Art 5: ESGO-EFC new recommendations on prevention
ESGO eAcademy, Murat Gultekin, 282757
State of the art in HPV vaccination: ESGO-EFC joint statement
ESGO eAcademy, Elmar Joura, 282758
SLN ultrastaging
ESGO eAcademy, Glenn McCluggage, 282764
Perspectives in novel treatments
ESGO eAcademy, Domenica Lorusso, 282750
Enhanced Recovery Hospital Implementation Process (ERAS): A holistic approach
ESGO eAcademy, Pedro Ramirez, 282756
Is there a role for radiotherapy in high-risk early-stage disease?
ESGO eAcademy, Carien Creutzberg, 282749
Pre- and postoperative care: Focussing on nutrition and immunonutrition
ESGO eAcademy, Annamaria Ferrero, 282755
Is there a role for chemotherapy in high-risk early-stage disease?
ESGO eAcademy, Mansoor R Mirza, 282748
Perioperative anaesthetic management
ESGO eAcademy, Carolyn Weiniger, 282754
Endometrial cancer: A single disease?
ESGO eAcademy, Tjalling Bosse, 282747
The role of the Intensive Care Unit (ICU) in postoperative management
ESGO eAcademy, Nikolaos Thomakos, 282753
Presidential lecture
ESGO eAcademy, Denis Querleu, 282744
Surgical performance
ESGO eAcademy, Karl Tamussino, 282742
QI related to patients´ management
ESGO eAcademy, Francesco Raspagliesi, 282741
How to develop and how to use QI
ESGO eAcademy, David Cibula, 282740
Lessons learned: EWOC-1/EORTC55944/ PORTEC-3*
ESGO eAcademy, Nicoletta Colombo, 282737
First line ovarian cancer trials: VELIA/Forward1
ESGO eAcademy, Mansoor R Mirza, 282736
PARP combination studies: PRIMA/PAOLO-1/ANVANOVA2
ESGO eAcademy, Jonathan Ledermann, 282735
CON: open radical hysterectomy should be the new standard of care
ESGO eAcademy, Pedro Ramirez, 282728
PRO: Minimally invasive radical hysterectomy should remain the standard approach
ESGO eAcademy, Henrik Falconer, 282727
ESGO eAcademy, Nadeem Abu Rustum, 286497
Development and validation of an endometrial carcinoma preoperative Bayesian network using molecular and clinical biomarkers (ENDORISK): an ENITEC collaboration study
ESGO eAcademy, Casper Reijnen, 286495
Prognostic relevance of the molecular classification in high-risk endometrial cancer: analysis of the PORTEC-3 trial
ESGO eAcademy, Alicia Leon-Castillo, 286496
Lympho-vascular space invasion is strongly associated with lymph node metastases and decreased survival in endometrioid endometrial cancer: a Swedish Gynecologic Cancer Group (SweGCG) study
ESGO eAcademy, Karin Stalberg, 286494
Conservative treatment of atypical endometrial hyperplasia and early endometrial cancer: a prospective single institution study of 418 patients
ESGO eAcademy, Olga Novikova, 286493
Update on chemotherapy and targeted therapy of high-grade serous carcinomas
ESGO eAcademy, Nicoletta Colombo, 282719
Quality assurance in ovarian cancer surgery
ESGO eAcademy, Andreas Du Bois, 282724
Surgical management of early, advanced, and recurrent adnexal carcinomas
ESGO eAcademy, Denis Querleu, 282718
Quality assurance in endometrial cancer surgery
ESGO eAcademy, Jan Persson, 282723
Pathology and pathologic markers of extra-uterine high-grade serous carcinoma
ESGO eAcademy, Glenn McCluggage, 282717
Quality assurance in cervical cancer surgery
ESGO eAcademy, Andreas Obermair, 282722
Laparoscopic scores to predict operability: Are they sufficient to stratify patients safely into surgical pathways?
ESGO eAcademy, Giovanni Scambia, 282708
The development of checkpoint inhibitor combinations: Which future?
ESGO eAcademy, Eric Pujade-Lauraine, 282714
How to incorporate tumour biology into tailoring surgical efforts
ESGO eAcademy, Christina Fotopoulou, 282707
How to detect and manage immunotherapy toxicity
ESGO eAcademy, Domenica Lorusso, 282713
Surgery at relapse: How to select optimal surgical candidates?
ESGO eAcademy, Andreas Du Bois, 282706
Checkpoint inhibitors in gynaecological cancers: What are the data?
ESGO eAcademy, Christian Marth, 282712
Fragility scores stratifying patients to radical upfront versus interval debulking surgery: Results of the TRUST- FRAGILE study
ESGO eAcademy, Felix Hilpert, 282705
Immunotherapy in gynae-oncology: Why and how?
ESGO eAcademy, Lana Kandalaft, 282711
ESGO eAcademy, Christina Fotopoulou, 286492
SENTIX - Sentinel lymph node in patients with cervical cancer: time to voiding recovery after surgery (CEEGOG-CX01; ENGOT-CX2; NCT02494063)
ESGO eAcademy, Ignacio Zapardiel, 286491
Frozen section examination of sentinel lymph nodes can be used as a decisional tool in the surgical management of early cervical cancer
ESGO eAcademy, Agnieszka Magdalena Rychlik, 286490
Surgical algorithm for sentinel lymph nodes detection in early-stage cervical cancer
ESGO eAcademy, Fabrice Lecuru, 286489
SUCCOR study. An international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 (FIGO 2009,< 4 cm) cervical cancer operated in 2013-2014
ESGO eAcademy, Luis Chiva, 286488
Role of NACT in cervical cancer
ESGO eAcademy, Stefano Greggi, 287797
Abnormal Colposcopy Interactive Case Series
ESGO eAcademy, Mihaela Grigore, 287798
Sexuality in cancer survivors
ESGO eAcademy, Annette Hasenburg, 287799
Immunotherapy of ovarian cancer
ESGO eAcademy, Jan Kotarski, 287800
Why brachytherapy is a crucial component of the management of cervical cancer
ESGO eAcademy, Cyrus Chargari, 287801
Definitive (chemo) radiotherapy of cervical cancer with nodal boost
ESGO eAcademy, Jacob Lindegaard, 287802
The IOTA system in the diagnosis of suspicious ovarian masses
ESGO eAcademy, Dirk Timmerman, 287803
Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery
ESGO eAcademy, Marlene Kranawetter, 287804
Challenges Facing Colposcopy
ESGO eAcademy, Charles Redman, 287805
Nutrition, endogenous hormone metabolism, and cancers of the breast, endometrium, and ovary
ESGO eAcademy, Rudolf Kaaks, 287806
Pharmacologic maneuvers to control bleeding in surgery
ESGO eAcademy, Jeremy Campbell, 287807
ESGO eAcademy, Willemien Van Driel, 287808
FIGO classification - Ongoing Challenges'
ESGO eAcademy, Sean Kehoe, 287809
Techniques of Radical Hysterectomy. On the shoulders of giants. Great ppt on the history of Radical hysterectomy.
ESGO eAcademy, Luis Chiva, 287810
Succor study
ESGO eAcademy, Luis Chiva, 287811
ESGO eAcademy, Ignace Vergote, 287812
Molecular tumour board in uterine sarcomas
ESGO eAcademy, Sigurd Lax, 287813
Cervical cancer prevention - a changing scene
ESGO eAcademy, Maria Kyrgiou, 287814
What you considered a leiomyoma appeared to be a sarcoma: What to do and how to prevent it?
ESGO eAcademy, Mehmet Meydanli, 287815
Challenge to prevent uterine sarcoma morcellation
ESGO eAcademy, Frederic Amant, 287816
New Generation Colposcopies
ESGO eAcademy, Murat Gultekin, 287817
The vaginal microbiome, HPV infection, and progression of cervical disease
ESGO eAcademy, Murat Gultekin, 287818
Laparoscopic radical trachelectomy: step by step
ESGO eAcademy, Ali Kucukmetin, 285194
Current indications for LND in epithelial ovarian cancer in the post-LION era
ESGO eAcademy, Christina Fotopoulou, 285141
Urinary diversion procedures in gynecologic oncologic surgery.
Part III: Laparotomic Miami Pouch in 10 steps
ESGO eAcademy, Carlos Martínez Gómez, 283327
Nerve sparing surgery
ESGO eAcademy, Berta Diaz Feijo, 280227
Urinary diversion procedures in gynecologic oncologic surgery.
Part II: Ileal orthotopic neobladder in 10 steps
ESGO eAcademy, Carlos Martínez Gómez, 279754
References & Assessment | Session 1 - Diagnostic pathways and patients
ESGO eAcademy, Course Faculty, 278028
References & Assessment | Session 2 - Endometrial cancer
ESGO eAcademy, Course Faculty, 278029
References & Assessment | Session 3 - Ovarian cancer and Borderline tumors
ESGO eAcademy, Course Faculty, 278030
References & Assessment | Session 4 - Cervical Cancer
ESGO eAcademy, Course Faculty, 278031
References & Assessment | Session 5 - Psychooncological care and follow up
ESGO eAcademy, Course Faculty, 278032
Surgery for cervical carcinoma after the LACC trial
ESGO eAcademy, Rene H.M. Verheijen, 276205
Urinary Diversion Procedures in Gynecologic Oncologic Surgery.
Part I: Bricker Ileal Conduit Urinary Diversion in 10 Steps
ESGO eAcademy, Faculty / Presenter(s), 276202
Tracers and corresponding detection devices : Technetium colloids
ESGO eAcademy, Kamil Zalewski, 276200
VuIvar cancer
ESGO eAcademy, Ate van der Zee, 276250
Sentinel node in breast cancer
ESGO eAcademy, Xavier Pivot, 276198
Anatomical basis of lymph node detection
ESGO eAcademy, Jan Persson, 276197
Anatomical basis of lymph node detection
ESGO eAcademy, Jan Persson, 276249
Endometrial cancer
ESGO eAcademy, Michel David Mueller, 276196
Fluorescence-guided radical hysterectomy
ESGO eAcademy, Fabrice Lecuru, 276195
Ongoing prospective studies on SLN only in cervical cancer, where are we standing?
ESGO eAcademy, Fabrice Lecuru, 276194
Cervical cancer: Accuracy of sentinel node in the detection of nodal metastases
ESGO eAcademy, Fabrice Lecuru, 276248
Ongoing clinical trials in gynecologic oncoly
ESGO eAcademy, Eric Leblanc, 276193
MIS in morbidly obese patients
ESGO eAcademy, Walter Gotlieb, 276192
Pathophysiological and anatomical basis: the transit of cancer cells in the lymphatic system
ESGO eAcademy, Walter Gotlieb, 276247
Tracers and corresponding detection devices : Blue dyes
ESGO eAcademy, H. Ferreira Carvalho, 276191
Processing and assessment of the sentinel node, molecular biology
ESGO eAcademy, Gerlinde Lang-Avérous, 276190
Sentinel node in melanoma
ESGO eAcademy, Cherif Akladios, 276189
The place of para-aortic dissection in endometrial cancer in the era of PET-CT and SLN
ESGO eAcademy, Nadeem Abu Rustum, 276188
Surgical technique: basics and pitfalls of pelvic SLN mapping
ESGO eAcademy, Nadeem Abu Rustum, 276246

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings